Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine

Gynecologic Oncology

Volumn 106, Issue 1, 2007, Pages 268-271

  Bianconi, M ^a   Jankilevich, G ^a   Otero, S ^a   Nassif, J ^a   Storino, C ^a  

^a HOSPITAL DURAND   (Argentina)

Author keywords

Capecitabine; Choriocarcinoma; Gestational trophoblastic neoplasia; Salvage therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CHORIONIC GONADOTROPIN; CISPLATIN; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURGERY; CASE REPORT; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; HAND FOOT SYNDROME; HIGH RISK PATIENT; HUMAN; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT; TREATMENT RESPONSE; TROPHOBLASTIC TUMOR;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CHORIOCARCINOMA; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; PREGNANCY; RISK FACTORS; SALVAGE THERAPY; TROPHOBLASTIC NEOPLASMS;

EID: 34250368072     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.04.002     Document Type: Article

References (10)

1. Hertz R., Li M.C., and Spencer D.B. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc. Soc. Exp. Biol. Med. 93 (1956) 361-366
2. Newlands E.S., Bagshawe K.D., Begent R.H., et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br. J. Obstet. Gynaecol. 98 (1991) 550-557
3. Kohorn E.I., Goldstein D.P., Hancock B.W., et al. Combining the staging system of the international Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for the Trophoblastic Neoplasia. Report of the Working Committee of the International society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int. J. Gynecol. Cancer 10 (2000) 84-88
4. Kavanagh J.J., Pecorelli S., Benedet J.L., et al. Trophoblastic disease. In: En Benedet J.L., and Hacker N.F. (Eds). Staging classifications and clinical practice guidelines of gynaecologic cancers by FIGO Committee on Gynecologic Oncology and IGCS Guidelines Committee. Second Ed. (2003) 119-140
5. Newlands E.S., et al. Results and toxicity using PE/EMA schedule in patients with gestational trophoblastic tumors. ASCO Proc. (2001) 1412
6. Piamsomboon S., Kudelka A.P., Termrungruanglert W., et al. Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature. Eur. J. Gynaecol. Oncol. 18 (1997) 453-456
7. Surwit E. High-risk metastatic gestational trophoblastic disease. J. Reprod. Med. 36 (1991) 45-48
8. Lurain J.R., Singh D.K., and Schink J.C. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J. Reprod. Med. 51 (2006) 773-776
9. Song Hz., Yanbg X.Y., and Xiang Y. Forty five years experience of the treatment of choriocarcinoma and invasive mole. Int. J. Gynaecol. Obstet. 60 Suppl. 1 (1998) S77-S83
10. Matsui H., Itusuka Y., Suzuka K., Yamazawa K., Mitsuhashi A., and Sekiya S. Salvage chemotherapy for high risk gestational trophoblastic tumor. J. Reprod. Med. 49 (2004) 438-442